Terapia Ranbaxy registers 30% increase in exports

Romanian drug producer Terapia Ranbaxy saw its exports increase by 30% last year, to almost 13 million dollars. “Faringosept (a brand of throat lozenges) is selling very well in Russia. Ranbaxy’s representative offices have taken over the reins of export activities, they have the means to bring about this expansion and understand these markets much better than Terapia can. This is a rise we have been expecting, and we target development in this direction in 2008, by introducing new drugs for our export products,” said Dragos Damian, CEO of Terapia Ranbaxy. The brand with the highest sales on the foreign markets was, as in 2006, Faringosept. Exports will be boosted this year by the introduction of new products; in particular those whose technology transfer will take place this year. “There are ten products involved in the technology transfer process from India to Cluj. Once this process is over, the products will be produced here, and then exported to countries in the former CIS area (former USSR states), as well as to Poland and the Baltic states,” added Damian.